The first quarter is in the books, and the best and worst performers are a pharmacy chain and a footwear company—certainly not the usual suspects. CVS Health was the N0. Deckers Outdoor did the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CLOV Clover Health Investments, Corp.

US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant.

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older ...

Prescribing guidelines and the benefits and risks of nirmatrelvir/ritonavir for COVID patients ...

Nirmatrelvir-ritonavir was beneficial for COVID-19 management in patients with chronic kidney disease or kidney failure, significantly reducing the risk of mortality and hospital admission.

Paxlovid ® (nirmatrelvir-ritonavir) for the treatment of COVID-19 in patients with chronic kidney disease (CKD) or kidney failure is associated with reduced risk for hospitalization, major adverse ...

Teams that fulfilled requests for government documents lost their jobs on Tuesday as part of the Trump administration's 10,000-person staff cuts at the Department of Health and Human Services. Their ...